Business ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Phase 2 Trials Product Development Drug Approval Partnerships Research and Development Drug Trials Patient Cohorts Phase 1 Studies

Kynam Trims Syndax Stake With $8.18 Million Q4 Sale Disclosed in SEC Filing

The remaining holding stayed sizable within the portfolio following a rally that lifted the quarter-end value.

Biofrontera Reports Record 2025 Revenue of $41.7 Million and Best-Ever Q4 at $17.1 Million

Tenon Medical Posts Record 2025 Revenue as SImmetry+ Wins FDA Clearance

Merck Sets $70 Billion Mid-2030s Revenue Goal at JPM Conference as Shares Dip

Eli Lilly Prepares €15 Billion Abivax Offer, Eyes Next Wave of Weight-Loss Drugs

AnaptysBio CMO Trims Stake After Option Exercise as Director Reports Separate Sale

MPM BioImpact Exits MBX, MoonLake, Crinetics in Q3, SEC Filing Shows

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Day One to Acquire Mersana in Backloaded Deal Worth Up to $285 Million

Arcutis Turns First Profit on Zoryve Surge, Lifts Outlook as Stock Jumps

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

Takeda Strikes $11 Billion-Plus Oncology Deal With Innovent, Pays $1.2 Billion Upfront

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

Jubilant Pharmova Q1 Profit Plunges 79% as CFO Resigns; Shares Slide

Glenmark Stock Hits Record High on $700 Million AbbVie Cancer Drug Deal

S&P 500 Gains 1% on Tesla Robotaxi Debut and Merger Speculation; Supermicro Shares Plunge

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders

Wegovy Approved for Heart Health, Faces Insurance Coverage Challenges